Quantum.Tech 2024

23rd September – Quantum.Tech Cryptography Spotlight Day | 24th – 25th September - Main Conference

Twickenham Stadium, London

Jens Kieckbusch

Associate Director, Emerging Innovations Astra Zeneca

I scout and evaluate early-stage opportunities for AZ with an impact horizon of 5-10 years. These activities are usually delivered in partnership with academic institutions, start-ups or internal stakeholders. Before joining AstraZeneca, I was a Partner in the business development team at The Wellcome Trust and led Wellcome’s product development efforts in cholera and vaccine development for other diseases with global health relevance. I hold a PhD in immunology from the University of Cambridge and completed further postdoctoral training in areas relevant to cell therapy and tissue regeneration.

MAIN CONFERENCE AGENDA DAY 1 - Tuesday 24th September

9:45 AM Are global enterprises quantum secure?

  • Are global enterprises acting with classical legacy architecture prepared for the impact quantum will have? 
  • Are the potential threats overblown or do we need to be worried? 
  • Is the threat of quantum bigger than the opportunity? 
  • Who is leading this is it the CTO, CIO or the CISO? 

2:40 PM How is the pharma industry seeing pragmatic returns on its quantum investments?

  • Is it the pharmaceuticals industry where we will see the big quantum breakthroughs in 2023? 
  • Is QC actually being successfully to advance drug discovery? 
  • Has the hype bubble burst, and if so are pharmaceutical companies having to adjust their expectations? 
  • Is the quantum opportunity being discussed in the boardroom or is it on the periphery? 
  • What R&D breakthroughs have been reached in the past year? 

Check out the incredible speaker line-up to see who will be joining Jens.

Download The Latest Agenda